| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $86.2M | -11.2% |
| R&D Expense | $164.5M | -5.5% |
| SG&A Expense | $45.5M | +39.8% |
| Operating Income | -$123.8M | -13.0% |
| Pre-tax Income | -$122.2M | -13.6% |
| Income Tax | -$433K | +98.5% |
| Net Income | -$121.8M | -54.1% |
| EPS (Basic) | -$5.91 | -50.8% |
| EPS (Diluted) | -$5.91 |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.0M | -23.1% |
| Accounts Receivable | $20.3M | -13.8% |
| Current Assets | $311.7M | -2.3% |
| Total Assets | $375.4M | -14.4% |
| Current Liabilities | $29.8M | -17.5% |
| Total Liabilities | $54.1M | +37.4% |
| Stockholders' Equity | $321.3M | -19.6% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.8M | -21.1% |
| Capital Expenditures | $2.1M | +183.3% |
| Investing Cash Flow | $54.9M | +48.4% |
| Financing Cash Flow | $20.0M | +550.4% |
| Free Cash Flow | -$86.9M | -22.8% |
| -50.8% |